A Scoping Review on COVID-19 Vaccine Hesitancy among the Lesbian, Gay, Bisexual, Transgender, Queer, Intersex and Asexual (LGBTQIA+) Community and Factors Fostering Its Refusal.

Jyotsna Needamangalam Balaji, Sreenidhi Prakash, Ashish Joshi, Krishna Mohan Surapaneni
Author Information
  1. Jyotsna Needamangalam Balaji: Panimalar Medical College Hospital & Research Institute, Varadharajapuram, Chennai 600-123, Tamil Nadu, India. ORCID
  2. Sreenidhi Prakash: Panimalar Medical College Hospital & Research Institute, Varadharajapuram, Chennai 600-123, Tamil Nadu, India. ORCID
  3. Ashish Joshi: School of Public Health, The University of Memphis, Memphis, TN 38152, USA.
  4. Krishna Mohan Surapaneni: SMAART Population Health Informatics Intervention Center, Foundation of Healthcare Technologies Society, Panimalar Medical College Hospital & Research Institute, Varadharajapuram, Chennai 600-123, Tamil Nadu, India. ORCID

Abstract

BACKGROUND: The ramifications of the existing crisis caused by the coronavirus pandemic are sensed in all walks of life. Among the various efforts made to curb the spread of this novel infection, the development of COVID-19 vaccines had a profound role in flattening the pandemic curve. Even though the rapid vaccine drive received a highly welcoming response among people, the reluctance and ignorance of a part of the population towards available safe vaccines stand as impediments to achieving the desired outcome. The LGBTQIA+ (Lesbian, Gay, Bisexual, Transgender, Queer, Intersex and Asexual) communities are the least studied groups in this regard.
OBJECTIVE: The purpose of this study is to extensively review and report on COVID-19 vaccine uptake and refusal among the LGBTQIA+ population and enumerate the factors contributing to vaccine hesitancy. The study extends further to outline a conceptual framework for interventions to enhance COVID-19 vaccine acceptance among the LGBTQIA+ population.
METHODS: We performed a systematic search using key terms on Google Scholar and PubMed. The obtained results were filtered using the eligibility criteria framed for this study. The initial search provided an extensive result of 4510 articles which were later screened at various levels to arrive at the final inclusive collection of manuscripts adding to 17. The studies were analyzed by the authors individually, and the data were categorized using variables. The results are interpreted using charts and graphs. The whole manuscript has been structured in accordance with the PRISMA extension for scoping reviews.
RESULT: The comprehensive search yielded 17 eligible articles for this review. Most of the studies were conducted in the United States (n = 17), and predominantly cross-sectional studies have been conducted. The major comparative factor was the HIV status of the LGBTQIA+ population. HIV-affected patients were more willing to take up COVID-19 vaccination. However, social stigma, discrimination, lack of access and non-prioritization in vaccine drives were found to be the major factors contributing to vaccine hesitancy among this population.
CONCLUSION: The invention of the COVID-19 vaccination revolutionized the healthcare systems burdened with COVID-19. Although this is a breakthrough scientific contribution, many factors are associated with the rate of vaccine acceptance, especially among sexual and gender minorities. The reviewed studies have revealed numerous factors that influence vaccine uptake and refusal with the commonest being concerns on discrimination, social stigma, inequitable access to healthcare, vaccine safety, efficacy, potency, side effects and lack of trust in medical workers. These impediments in vaccine coverage should be meticulously addressed to ensure optimum LGBTQIA+ physical and mental health as well as for providing non-discriminative, equitable and quality healthcare service regardless of the gender or sexual orientation of individuals.

Keywords

References

  1. Vaccines (Basel). 2021 Mar 01;9(3): [PMID: 33804530]
  2. Lancet. 2022 Feb 5;399(10324):501-503 [PMID: 34953522]
  3. LGBT Health. 2021 Jul;8(5):322-329 [PMID: 34115955]
  4. Infect Dis Clin North Am. 2022 Jun;36(2):295-308 [PMID: 35636901]
  5. Front Psychol. 2022 May 19;13:876116 [PMID: 35664204]
  6. Vaccine. 2015 Aug 14;33(34):4161-4 [PMID: 25896383]
  7. J Infect Dis. 2021 Dec 1;224(11):1810-1820 [PMID: 34323998]
  8. Ann Intern Med. 2018 Oct 2;169(7):467-473 [PMID: 30178033]
  9. J Urban Health. 2021 Feb;98(1):27-40 [PMID: 33259027]
  10. MMWR Morb Mortal Wkly Rep. 2022 Feb 04;71(5):171-176 [PMID: 35113846]
  11. Hum Vaccin Immunother. 2021 Dec 2;17(12):4971-4981 [PMID: 34890297]
  12. Bull World Health Organ. 2018 Sep 1;96(9):644-653 [PMID: 30262946]
  13. AIMS Public Health. 2021 Mar 23;8(2):303-308 [PMID: 34017893]
  14. Infect Dis Rep. 2021 Oct 07;13(4):872-887 [PMID: 34698208]
  15. BMC Public Health. 2022 Jan 18;22(1):122 [PMID: 35042491]
  16. AIDS Behav. 2022 Aug;26(8):2692-2702 [PMID: 35132480]
  17. Brain Behav Immun Health. 2021 Aug;15:100277 [PMID: 34036287]
  18. Am J Public Health. 2022 Mar;112(3):405-407 [PMID: 35196061]
  19. Open Forum Infect Dis. 2022 May 20;9(7):ofac260 [PMID: 35855958]
  20. Vaccines (Basel). 2022 Mar 09;10(3): [PMID: 35335045]
  21. Vaccines (Basel). 2021 Feb 16;9(2): [PMID: 33669441]
  22. LGBT Health. 2017 Feb;4(1):4-10 [PMID: 28113005]
  23. J Behav Med. 2022 Apr 27;: [PMID: 35476250]
  24. J Adolesc Health. 2018 Oct;63(4):383-393 [PMID: 30146436]
  25. Int J Environ Res Public Health. 2021 Jul 07;18(14): [PMID: 34299711]
  26. Int J Environ Res Public Health. 2022 Apr 28;19(9): [PMID: 35564769]
  27. Infect Dis Rep. 2021 Oct 03;13(4):865-871 [PMID: 34698177]
  28. LGBT Health. 2020 Aug-Sep;7(6):279-282 [PMID: 32790495]
  29. AIDS Behav. 2022 Aug;26(8):2531-2538 [PMID: 35102499]
  30. Psychiatry Res. 2022 Mar;309:114391 [PMID: 35032764]
  31. SAGE Open Nurs. 2021 Oct 16;7:23779608211051174 [PMID: 34869861]
  32. PLoS One. 2022 Jul 8;17(7):e0271162 [PMID: 35802684]
  33. PLoS One. 2022 Mar 31;17(3):e0266120 [PMID: 35358267]
  34. PLoS One. 2016 Jan 05;11(1):e0146139 [PMID: 26731405]
  35. Public Health. 2021 May;194:245-251 [PMID: 33965796]
  36. Diabetes Metab Syndr. 2020 Nov-Dec;14(6):1757-1758 [PMID: 32942251]
  37. Transl Behav Med. 2020 Oct 12;10(5):1200-1210 [PMID: 33044540]
  38. Am J Public Health. 2022 Jan;112(1):17-20 [PMID: 34936395]
  39. Soc Sci Med. 2013 May;84:22-9 [PMID: 23517700]
  40. Vaccines (Basel). 2021 Jul 05;9(7): [PMID: 34358161]
  41. Front Med (Lausanne). 2022 Mar 11;9:838973 [PMID: 35360721]
  42. Clin Transl Med. 2020 Feb 20;9(1):19 [PMID: 32078069]
  43. Int J Environ Res Public Health. 2022 Sep 21;19(19): [PMID: 36231229]
  44. AIDS Patient Care STDS. 2022 Nov;36(11):416-424 [PMID: 36367994]

Word Cloud

Created with Highcharts 10.0.0vaccineCOVID-19LGBTQIA+amongpopulationfactorsusingstudiesvaccinesstudyrefusalhesitancysearch17healthcarepandemicvariousimpedimentsLesbianGayBisexualTransgenderQueerIntersexAsexualreviewuptakecontributingacceptanceresultsarticlesconductedmajorvaccinationsocialstigmadiscriminationlackaccesssexualgenderBACKGROUND:ramificationsexistingcrisiscausedcoronavirussensedwalkslifeAmongeffortsmadecurbspreadnovelinfectiondevelopmentprofoundroleflatteningcurveEventhoughrapiddrivereceivedhighlywelcomingresponsepeoplereluctanceignoranceparttowardsavailablesafestandachievingdesiredoutcomecommunitiesleaststudiedgroupsregardOBJECTIVE:purposeextensivelyreportenumerateextendsoutlineconceptualframeworkinterventionsenhanceMETHODS:performedsystematickeytermsGoogleScholarPubMedobtainedfilteredeligibilitycriteriaframedinitialprovidedextensiveresult4510laterscreenedlevelsarrivefinalinclusivecollectionmanuscriptsaddinganalyzedauthorsindividuallydatacategorizedvariablesinterpretedchartsgraphswholemanuscriptstructuredaccordancePRISMAextensionscopingreviewsRESULT:comprehensiveyieldedeligibleUnitedStatesn=predominantlycross-sectionalcomparativefactorHIVstatusHIV-affectedpatientswillingtakeHowevernon-prioritizationdrivesfoundCONCLUSION:inventionrevolutionizedsystemsburdenedAlthoughbreakthroughscientificcontributionmanyassociatedrateespeciallyminoritiesreviewedrevealednumerousinfluencecommonestconcernsinequitablesafetyefficacypotencysideeffectstrustmedicalworkerscoveragemeticulouslyaddressedensureoptimumphysicalmentalhealthwellprovidingnon-discriminativeequitablequalityserviceregardlessorientationindividualsScopingReviewVaccineHesitancyCommunityFactorsFosteringRefusal

Similar Articles

Cited By